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1. Introduction 
Injection of heparin releases two lipases into the 
circulating blood. One, lipoprotein lipase, originates 
from extrahepatic tissues [ I]. The physiological role 
of this lipase is to hydrolyze triacylglycerols and phos- 
pholipids in chylomicrons and very low density lipo- 
proteins [ 11. The other lipase comes from the liver 
[2]. It is generally assumed that also this lipase has an 
important role in lipoprotein metabolism, but it is 
now known what its physiological substrate is. We 
demonstrate here binding of thislipase to high density 
lipoproteins. 
2. Materials and methods 
Human postheparin plasma was obtained from male 
donors 10 min after intravenous injection of 100 I.U. 
heparin/kg body weight. The lipase of hepatic origin 
was partially purified by adsorption of the postheparin 
plasma with heparin-Sepharose [3]. It was further 
purified by adsorption to heparin which had been 
modified by partialN-desulfation followed by acetyla- 
tion of exposed amino groups [4]. This step removed 
antithrombin from the lipase preparation. The specific 
activity of a typical preparation was 50 pm01 fatty 
acids released/min X mg (pH 8.5,25’C) against a gum 
arabic stabilized emulsion of [3H] trioleoylglycerol. 
Human high density lipoproteins were prepared by 
ultracentrifugation of normal plasma. Very low density 
lipoproteins and low density lipoproteins were first 
flotated by centrifugation at d 1.063 g/cm3 for 24 h 
at 36 000 rev./min in a Beckman Ti 50 rotor, 15°C. 
High density lipoproteins were then prepared by cen- 
trifugation of the infranatant at d 1.21 g/cm3 for 48 h 
at 36 000 rev./min. In one experiment a subfraction 
of high density lipoproteins isolated in the density 
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range 1.125-l .21 g/cm3 was used (high density lipo- 
proteins3). The lipoproteins were dialyzed against 
0.1 M NaCl 10 mM Tris/Cl pH 8.5. The concentration 
of high density lipoproteins used in the experiments 
is expressed as protein determined by the Lowry 
method. 
High density lipoprotein-Sepharose was prepared 
by mixing CNBr-activated Sepharose (Pharmacia, 
Uppsala, Sweden) with high density lipoproteins 
(10 mg protein/ml gel) in 0.1 M NaHC03, 0.5 M NaCl 
at 4°C over night. Remaining activated sites on the 
Sepharose were blocked by 0.1 M ethanolamine 
(pH 8). The gel was washed with the carbonate buffer, 
then with 0.1 M acetate pH 4 and stored in 10 mM 
phosphate, 0.1 M NaCl, pH 7.4 with 0.2% sodium 
azide. All experiments were carried out within two 
weeks after the preparation of the gel. Unsubstituted 
Sepharose 4B was used as a control. Human apolipo- 
protein CIIIz was prepared from human very low 
density lipoproteins as described [5]. 
Intralipid 10% containing [ 14C] oleic acid-labeled 
trioleoylglycerol was donated by AB Vitrum, 
Stockholm, Sweden. The triacylglycerol-rich particles 
were separated from the excess phospholipids by flo- 
tation through 20 mM Tris/Cl, 0.1 M NaCl, pH 8.5 by 
centrifugation for 20 min in a Beckman SW-50: 1 rotor 
at 25 000 rev./min [5]. The top layer was recovered 
and dispersed in buffer. Albumin was a fraction V 
preparation from Sigma, St. Louis, MO., USA. The 
release of labeled fatty acids was determined as 
described [5]. Deoxycholate was from Merck, 
Darmstadt, F. R. G. 
3. Results 
The activity of the hepatic heparin-releasable lipase 
against a triacylglycerol emulsion was strongly inhib- 
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Fig.1. Inhibition of the lipase activity by high density lipo- 
proteins. Triacylglycerol-rich particles from ‘%Z-labeled Intra- 
lipid corresponding to4 mg triacylglycerol/ml, 0.1 M NaCl, 
0.2 M Tris/Cl, 60 mg albumin/ml, pH 8.5. (0) 25”C, (0) 10°C. 
The indicated amounts of high density lipopqoteins were 
added 10 min before the enzyme. Serial samples of 0.2 ml 
were withdrawn and the amount of free fatty acids deter- 
mined. In all cases hydrolysis was linear with time. 
ited by high density lipoproteins (fig.1). Kinnunen 
and Ehnholm have shown that C-apolipoproteins 
inhibit the activity of the hepatic lipase against a gum 
arabic stabilized triacylglycerol emulsion [6]. Inhibi- 
tion with apolipoprotein CIIIz was obtained also with 
the present phosphatidylcholine stabilized trioleoyl- 
glycerol emulsion (fig.2). The mechanism of this inhi- 
bition is presumably that the apohpoprotein competes 
with the lipase for the same binding sites on the 
emulsion droplets. However, the inhibition by high 
density lipoproteins was obtained also with the sub- 
fraction high density lipoproteins although these con- 
tain only small amounts of C-apolipoproteins (not 
shown). Furthermore,high density Iipoproteins caused 
inhibition also at 10°C (fig.1) although this low tem- 
perature impedes the transfer of apolipoproteins [7]. 
When the emulsion droplets were preincubated with 
apolipoprotein CIIIz and then separated from unbound 
apolipoprotein by centrifugation the inhibition per- 
sisted (fig.2). In contrast, the inhibition caused by 
high density lipoproteins was fully relieved when the 
droplets were separated from the lipoproteins by cen- 
trifugation (fig.2). Thus, the inhibition could not be 
accounted for by transfer of apolipoproteins from the 
high density lipoproteins to the emulsion droplets but 
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Fig.2. Relief of the inhibition by removal of the high density 
lipoproteins from the medium. Media of the same composi- 
tion as in Iig.1, but without albumin were incubated with 
high density lipoproteins or with apolipoprotein CIII, for 
10 min at 25°C. To 2 ml of the media 100 mg sucrose/ml 
was added. These samples were then layered under 3 ml 
0.1 M NaCl, 0.2 M T&/Cl pH 8.5 and centrifuged in a 
Beckman SW SO:1 rotor at 30 000 rev./min for 20 min. The 
flotated lipid droplets were recovered after slicing the tubes 
and were suspended in the original volume of buffer. They 
were then used as substrate for incubations under the same 
conditions as in fig.1 (25°C). (0) medium preincubated with 
high density lipoproteins, no centrifugation. The final incuba- 
tion medium contained 50 pg high density lipoproteins/ml. 
(0) Medium preincubated with hiih density lipoproteins, 
then separated by centrifugation. (0) Medium preincubated 
with apolipoprotein CIII,, no centrifugation. The final incu- 
bation medium contained 50 pg CIII,/ml. (m) Medium prein- 
cubated with apolipoprotein CIII,, then separated by centrif- 
ugation. (A) NO addition during preincubktion, then separated 
by centrifugation. 
required the presence of the high density lipoproteins 
themselves. 
When the lipase was incubated with Sepharose- 
bound high density lipoproteins about two-thirds of 
the enzyme bound to the gel (table 1). In contrast 
only small amounts bound to unsubstituted Sepharose. 
The bound enzyme could be displaced by addition of 
free high density lipoproteins demonstrating that 
binding was indeed to the immobilized lipoproteins. 
The enzyme could also be eluted by deoxycholate. 
4. Discussion 
This study demonstrates that the hepatic heparin 
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Table 1 
Binding of the Iipase to high density lipoprotein-Sepharose 
High density lipopro- Unsubstituted 
tein-Sepharose Sepharose 
Exp. 1 Exp. 2 
Hepatic Iipase activity 
(%) 
Not bound 30 30 78 
Wash 1 3 5 10 
Wash 2 2 1 0 
HDL 1 30 0 
HDL 2 18 0 
HDL 3 4 0 
HDL 4 1 0 
Wash 3 1 0 
Wash 4 1 0 
Deoxycholate 1 2 44 1 
Deoxycholate 2 0 5 0 
200 ~1 of the gels were equilibrated in test tubes with 0.1 M 
NaCI, 20 mM Tris/Cl pH 8.5 containing 10 mg bovine serum 
albumin/ml. The tubes were centrifuged for 1 min at 4°C in 
a Beckman Minifuge and the supernatants were then removed. 
50 tig hepatic Iipase In 0.8 ml of the equilibration buffer was 
added to the gels and the tubes were gently shaken at 4°C for 
30 min. After centrifugation the supernatants were removed 
and the Iipase activity not bound was determined using a 
gum arabic stabilized emulsion of labeled trioleoylglycerol 
[ 31. The gels were washed twice with 0.8 ml of the equilibra- 
tion buffer (wash 1 and 2). Then, 0.8 ml of the equitibration 
buffer containing 5 mg high density lipoprotein/ml was 
added to the gels and the tubes were shaken for 30 min. 
After centrifugation the supernatants were removed and their 
content of Iipase activity was determined (HDL 1). The elu- 
tion with high density lipoprotein was repeated 3 times (HDL 
2.4). Then the gels were washed twice with 0.8 ml equilibra- 
tion buffer (wash 3 and 4). Finally the gels were eluted with 
2 successive 0.8 mI volumes of 5 mM deoxycholate in 20 mM 
Tris/CI pH 8.5 (deoxycholate 1 and 2). In experiment 2, the 
elution with high density lipoprotein was omitted. The total 
lipase activities in the supematants are expressed as per cent 
of the lipase activity initially added to the gels 
releasable lipase binds to high density lipoproteins. 
The inhibition of the lipase activity against synthetic 
emulsions seen in this study with high density lipo- 
proteins and in many previous studies with whole 
plasma is thus due to a competition for the enzyme 
between high density lipoproteins and the emulsion 
droplets. When the lipoproteins were removed from 
the incubation medium, hydrolysis of the emulsion 
droplets was again rapid demonstrating that the inhi- 
bition was dependent on the presence of the lipopro- 
tein particles. 
In vitro the hepatic lipase is able to hydrolyze acyl- 
glycerols in all major classes of lipoproteins [g-lo]. 
However, from several lines of evidence it has been 
concluded that in vivo this enzyme acts mainly on 
high density lipoproteins [2,11]. The higher affinity 
of the hepatic lipase for high density, lipoproteins 
than for triacylglycerol-rich particles demonstrated in 
the present study may be the mechanism by which 
the enzyme selects its physiological substrate from 
the various types of lipoproteins which circulate in 
plasma. 
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